Trial Details

SUSPENDED
Basic Information
Clinical ID c4085
Identifier NCT01076699
Trial Title A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions DRUG: 0.075 mg RVX-100|DRUG: 0.125 mg RVX-100|DRUG: 0.250 mg RVX-100|DRUG: placebo
Participant Information
Sponsor Revogenex, Inc.
City Chevy Chase
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2010-03
Primary Completion Date 2010-12
Completion Date 2011-03